SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.53 Cr | ₹0.58 Cr | ₹0.28 Cr | ₹0.33 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.53 Cr |
| Mar2024 | ₹0.58 Cr |
| Mar2020 | ₹0.28 Cr |
| Mar2019 | ₹0.33 Cr |
How is Deferred Tax Assets / Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.53 Cr | -8.46 | |
| Mar2024 | ₹0.58 Cr | 110.55 | |
| Mar2020 | ₹0.28 Cr | -17.17 | |
| Mar2019 | ₹0.33 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹557.2 Cr | -2.9% | -4.5% | -37% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.9% |
-4.5% |
-37% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses